Arranta Bio acquires Captozyme to accelerate microbiome development
Category: #health  By Mateen Dalal  Date: 2019-11-14
  • share
  • Twitter
  • Facebook
  • LinkedIn

Arranta Bio acquires Captozyme to accelerate microbiome development
  • Arranta has established a Center of Excellence for microbiome development
     
  • The acquisition will help quicken the delivery of LBPs for clients worldwide

Arranta Bio, a leading Contract Development Manufacturing Organization, recently announced that it has acquired Captozyme. The company also announced that it has subsequently established a Center of Excellence for the analytical and process development as well as the initial clinical supply for microbiome clients, as the Captozyme team and facilities got transferred from Gainesville, Florida to Arranta.

Captozyme had been formed in 2009 and has been the leading provider of development services to microbiome firms with the help of a team that has developed processes for more than 125 various species and 80 different genera over the past decade.

Captozyme had established GMP clinical capacity in 2018 and had effectively since scaled processes up to 400L scale fermentation via encapsulation and lyophilization.

Dr. Aaron Cowley, Captozyme’s Founder and Chief Technical Officer, now CTO of Arranta, stated that Captozyme has spent a decade to develop processes for clients with more than 125 bacteria which also includes organisms that are difficult to make. The team will now expand its capacity to serve the sector of microbiome as part of Arranta.

Cowley further commented that the company will now be able to steer the products of the clients from clinical phases to commercialization with the help of their enhanced capabilities. 

Arranta’s Founder, CEO and President, Mark Bamforth said that the company will welcome the team from Captozyme and praised the founder, Dr. Cowley, for his foresight in building expertise in the field of microbiome.

Bamforth added that the acquisition will help quicken the live biopharmaceutical products (LBPs)’ clinical 0delivery and to the clients and eventually through licensure to patients across the world.  

The goal for Arranta is to stand as the best microbiome contract development and manufacturing organization (CDMO) that is able to offer LBPs for all the pioneers in microbiome-related product through isolation, encapsulation, bacterial fermentation, and lyophilization.

 

Source Credit- https://www.prnewswire.com/news-releases/arranta-bio-announces-the-acquisition-of-captozyme-creating-a-center-of-excellence-for-microbiome-development-and-clinical-supply-300956937.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

AstraZeneca to present results of Farxiga’s DAPA-CKD trial at ESC 2020
AstraZeneca to present results of Farxiga’s DAPA-CKD trial at ESC 2020
By Mateen Dalal

According to reliable sources, British-Swedish multinational pharmaceutical company AstraZeneca plc will present the much awaited results of the Phase III DAPA-CKD trial of Farxiga in CKD (chronic kidney disease) at ESC Congress 2020. Sources with r...

FDA grants Emergency Use Authorization to Abbott’s COVID-19 antigen
FDA grants Emergency Use Authorization to Abbott’s COVID-19 antigen
By Mateen Dalal

Abbott Laboratories, a U.S.-based medical devices and healthcare firm, has reportedly received the Emergency Use Authorization (EUA) from the U.S. FDA (Food and Drug Administration) for the detecting COVID-19 virus with its portable antigen test Bina...

Hyundai Wia Corp. signs gun parts export contract with BAE Systems
Hyundai Wia Corp. signs gun parts export contract with BAE Systems
By Mateen Dalal

Hyundai Wia Corp., a South Korea-based defense firm, has reportedly signed gun parts export contract with BAE Systems plc of worth USD 100 million via a pre-value accumulation system. As per the agreement, Hyundai Wia will supply over 106 types of gu...